Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I / IIa Clinical Trial for Patients With Hepatitis C or B Virus Derived Liver Cirrhosis by CBP / β Catenin Inhibitor PRI-724

NCT03620474 is registered in ClinicalTrials.gov with Kiminori Kimura, MD as lead sponsor.

NCT NCT03620474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03620474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I / IIa Clinical Trial for Patients With Hepatitis C or B Virus Derived Liver Cirrhosis by CBP / β Catenin Inhibitor PRI-724
Lead sponsor
Kiminori Kimura, MD
Phase
Phase 1/2
Overall status
Completed
Start date
July 24, 2018
Completion date
February 28, 2022
Enrollment
27 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b, hepatitis c, liver cirrhoses